MedPath

BALSULPH OPH LIQ 10.0%

BALSULPH OPH LIQ 10.0%

Discontinued
DIN Number

00772313

Drug Class

Human

Market Date

Dec 31, 1989

Company
HC

bausch & lomb canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00772313
AIG Number0106092001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01AB04 SULFACETAMIDE
Product Specifications
Dosage FormDrops
Route of AdministrationOphthalmic
AHFS Classification52:04.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

SULFACETAMIDE SODIUMActive
Strength: 100 MG / ML
Monograph: SULFACETAMIDE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.